Jawaharlal Nehru University, New Delhi
New findings in leishmania described from India, Germany and the United States
Published in Elder Law Weekly, June 14th, 2006
Study 1: Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniasis.
According to recent research published in the journal Vaccine, "Visceral leishmaniasis, caused by the intracellular parasite Leishmania donovani is a significant public health problem in many regions of the world. Anti-leishmanial immune defenses are primarily dependent on the ability of the host to mount an interleukin-12 (IL-12) driven Th1 type of responses. Thus, IL-12 plays a pivotal role in diversification...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
Source: Elder Law Weekly (2006-06-14)
More Articles from Elder Law Weekly
- Amarin Corp. plc
Amarin acquires Parkinson disease drug candidate - Axonyx, Inc.
Axonyx completes multiple-dose phase I study of Posiphen - Fred Hutchinson Cancer Research Center, Seattle
Body mass index and hormone therapy interactions correlate with specific breast cancers - VA of Puget Sound Health Care Systems
Caenorhabditis elegans possesses molecular pathways that influence human tau-induced pathology - ANM Healthcare Solutions
Effects of collagen-based dietary supplement on college athletes' joint injuries studied - Aachen University of Technology
Researchers from Aachen University of Technology report details of new studies and findings - More from this issue of Elder Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
